| Authors: |
Park JJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC., Chu A; Division of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI., Li J; Department of Biostatistics, University of Michigan, Ann Arbor, MI., Ali A; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI., McKay RR; Moores Cancer Center, University of California San Diego, La Jolla, CA., Hwang C; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health System, Detroit, MI., Labriola MK; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC., Jang A; Tulane Cancer Center, Tulane University, New Orleans, LA., Kilari D; Department of Medicine, Froedtert Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Mo G; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA., Ravindranathan D; Winship Cancer Institute of Emory University, Atlanta, GA., Graham LS; University of Colorado Anschutz Medical Campus, Aurora, CO., Sokolova A; Division of Medical Oncology, Oregon Health Science University, Portland, OR., Tripathi A; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA., Pilling A; Division of Hematology/Oncology, Department of Internal Medicine, Henry Ford Health System, Detroit, MI., Jindal T; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Ravindra A; Holden Comprehensive Cancer Center, Iowa City, IA., Cackowski FC; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Sweeney PL; Tulane Cancer Center, Tulane University, New Orleans, LA., Thapa B; Department of Medicine, Froedtert Cancer Center, Medical College of Wisconsin, Milwaukee, WI., Amery TS; Division of Medical Oncology, Oregon Health Science University, Portland, OR., Heath EI; Karmanos Cancer Institute, Wayne State University, Detroit, MI., Garje R; Miami Cancer Institute, Miami, FL., Zakharia Y; Holden Comprehensive Cancer Center, Iowa City, IA., Koshkin VS; Division of Hematology and Oncology, Department of Medicine, University of California San Francisco, San Francisco, CA., Bilen MA; Winship Cancer Institute of Emory University, Atlanta, GA., Schweizer MT; University of Washington/Fred Hutchinson Cancer Center, Seattle, WA., Barata PC; Tulane Cancer Center, Tulane University, New Orleans, LA., Dorff TB; Department of Medical Oncology & Experimental Therapeutics, City of Hope Comprehensive Cancer Center, Duarte, CA., Cieslik M; Division of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI., Alva AS; Division of Hematology and Oncology, Department of Medicine, University of Michigan, Ann Arbor, MI., Armstrong AJ; Duke Cancer Institute Center for Prostate and Urologic Cancers, Duke University, Durham, NC. |
